Short bowel syndrome and study of the absorption of antibiotics with good oral bioavailability - GRAA

Centre Hospitalier Régional Universitaire de Nancy0 个研究点目标入组 10 人开始时间: 2021年5月10日最近更新: 2024年7月15日

试验速览

暂无简介。

•1. Male or female = 18 years of age ; ;
•2. Patient with short bowel syndrome
•3. Patient treated for urinary parenchymal infection (pyelonephritis / prostatitis) (documented with antibiogram) with SULFAMETHOXAZOLE/TRIMETHOPRIME / AMOXICILLINE (+/- acide clavulanique)/ OFLOXACINE / LEVOFLOXACINE
•4. Patient hospitalized in the Nutritional Assistance Unit or in the Infectious and Tropical Diseases Department
•5. Patient affiliated with to beneficiary of a social security system;
•6. Patient having performed a preliminary clinical examination
•7. Patient who signed informed consent
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 10
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•1. Patient at foreseeable risk of degrading their PO absorption capacity during follow-up;
•2. Patient on dialysis;
•3. Female of childbearing age without effective contraception;
•4. Person with a known allergy to one of the components of the evaluated product;
•5. Person with a contraindication to (or one of the) evaluated product (s);
•6. Persons referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of
•the Public Health Code:
•o Pregnant women, parturient women or nursing mothers ;
•o Minor (non-emancipated)
•o Adult person subject to a legal protection measure (guardianship,
•curatorship, judicial safeguard);
•o Adults person who is unable to give consent and who is not subject
•to a legal protection measure;
•o Persons deprived of their liberty by a judicial or administrative
•o Persons subject to psychiatric care pursuant to articles L. 3212-1 and

发起方

Centre Hospitalier Régional Universitaire de Nancy